The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody

INTRODUCTION: At present, there is an urgent need for the rapid and accurate detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies (NAbs) to evaluate the ability of the human body to resist coronavirus disease 2019 (COVID-19) after infection or vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yizhe, He, Jinyong, Zhang, Ying, Liang, Dan, Zhang, Jiaqi, Ji, Ruili, Wu, Yue, Su, Zejie, Ke, Changwen, Xu, Ning, Tang, Yong, Xu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509472/
https://www.ncbi.nlm.nih.gov/pubmed/37736103
http://dx.doi.org/10.3389/fcimb.2023.1203625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509472/
https://www.ncbi.nlm.nih.gov/pubmed/37736103
http://dx.doi.org/10.3389/fcimb.2023.1203625

Ejemplares similares